LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

Ken A. Olaussen, Ariane Dunant, Pierre Fouret et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

Medicine, Molecular Biology, Oncology +16

LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p

Wei Nie, Huijuan Ge, Xiaoqun Yang et al. · Cancer Letters · 2015 · 360 citations

Medicine, Genetics, Oncology +14

Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway

Yun Cui, Fuming Zhang, Chunkai Zhu et al. · Oncotarget · 2017 · 216 citations · Full text

Medicine, Molecular Biology, Oncology +17

LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells

Weidong Li, Xuesong Dong, Changjun He et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 207 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA

Minjun Du, Yanjiao Zhang, Yousheng Mao et al. · Biochemical and Biophysical Research Communications · 2016 · 192 citations

Life Sciences, Molecular Biology, Oncology +16